Results 11 to 20 of about 1,894 (150)

Citrullinemia stimulation test in the evaluation of the intestinal function [PDF]

open access: yesNutrición Hospitalaria, 2013
Background: Citrullinemia is been reported as a quantitative parameter of the enterocyte mass and function. Aim: The objective of this research is to analyse the value of fasting and stimulated citrullinemias in the intestinal function evaluation ...
Beatriz Pinto Costa   +5 more
doaj   +3 more sources

First manifestation of citrullinemia type I as Sandifer syndrome [PDF]

open access: yesThe Turkish Journal of Pediatrics, 2017
We report an eleven-month-old infant girl who presented as Sandifer syndrome clinically but was later diagnosed with citrullinemia type I. Metabolic evaluation and molecular analysis confirmed the correct diagnosis.
Mustafa Kılıç   +5 more
doaj   +2 more sources

ASS1 gene mutation in a neonate with citrullinemia type Ⅰ [PDF]

open access: yesJichu yixue yu linchuang, 2020
Objective To detect blood acylcarnitine and genes in a newborn with suspected citrullinemia, and to detect gene mutations in their parents, so as to clarify their diagnosis and follow-up investigations.
LYU Ya-nan, SONG Dong-po, WANG Wei-qing, CHEN Yan-ping
doaj   +1 more source

A Case of Acrodermatitis Dysmetabolica in a Child Affected by Citrullinemia Type I: When Early Diagnosis and Timely Treatment Are Not Enough [PDF]

open access: yesChildren, 2023
An infant with a prenatal diagnosis of citrullinemia, who started standard treatment at birth (L-arginine; sodium benzoate and a personalized diet characterized by a low protein intake and supplementation of essential nutrients and amino acids ...
Laura Bruni   +7 more
doaj   +3 more sources

Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9

open access: yesMolecular Therapy: Methods & Clinical Development, 2023
Citrullinemia type I is a rare autosomal-recessive disorder caused by deficiency of argininosuccinate synthetase (ASS1). The clinical presentation includes the acute neonatal form, characterized by ammonia and citrulline accumulation in blood, which may ...
Michela Lisjak   +8 more
doaj   +2 more sources

Prenatal diagnosis of citrullinemia type 1; seven families with c.1168G > A mutation of Argininosuccinate synthetase 1 gene in Southwest Iran: A case series [PDF]

open access: yesInternational Journal of Reproductive BioMedicine, 2022
Background: Citrullinemia type 1 is an autosomal recessive disease resulting in ammonia accumulation in the blood, and if uncontrolled may progress to coma or death in the early months after birth.
Maryam Hassanlou   +2 more
doaj   +2 more sources

Electroencephalography and transcranial Doppler ultrasonography in neonatal citrullinemia

open access: yesJournal of the Formosan Medical Association, 2014
The authors present a case of citrullinemia with a genotype of argininosuccinate synthetase (ASS1), c.380 G>A (p.R127Q)/c.380 G>A (p.R127Q), in two alleles. A 3-day-old female infant presented with status epilepticus and coma.
Pen-Hua Su   +5 more
doaj   +2 more sources

Citrullinemia type I and hypertrophic pyloric stenosis in a 1-month old male infant

open access: yesClinics and Practice, 2013
Citrullinemia type I (CTLN1) is an inherited urea cycle disorder, now included in most newborn screening panels in the US and Europe. Due to argininosuccinate synthetase deficiency, CTLN1 can lead to recurrent hyperammonemic crisis that may result in ...
Yoona Rhee   +3 more
doaj   +2 more sources

High Blood Pressure in a Urea Cycle Disorder: Case Report

open access: yesAmerican Journal of Perinatology Reports, 2020
Introduction Urea cycle disorders (UCDs) form a group of metabolic pathological conditions that might develop serious neurological consequences. Early diagnosis, before irreversible damage is established, is the most important prognostic and morbidity ...
Carolina Solé   +2 more
doaj   +2 more sources

Analysis of ASS1 gene in ten unrelated middle eastern families with citrullinemia type 1 identifies rare and novel variants [PDF]

open access: yesMolecular Genetics & Genomic Medicine, 2023
Background Citrullinemia type 1 (CTLN1) is a rare autosomal recessive disease caused by argininosuccinate synthetase (ASS) deficiency. Manifestations vary from the acute neonatal or “classic” form to a milder, late‐onset, or “unconventional” form.
Melissa Daou   +9 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy